Journal of Family Medicine and Primary Care,
Journal Year:
2025,
Volume and Issue:
14(3), P. 997 - 1002
Published: March 1, 2025
Diabetic
Nephropathy
(DN)
constitutes
nearly
half
of
cases
end
stage
renal
disease.
Despite
decrease
in
kidney
function,
eGFR
the
early
stages
may
remain
unaltered,
making
diagnosis
difficult
pointing
towards
need
more
accurate
biomarkers
for
detection.
Altered
serum
Matrix
Metallo-Proteinase-7
(MMP-7)
and
transforming
growth
factor-
β
(TGF-β)
has
been
noted
independently
diabetic
complications.
The
role
MMP-7
with
TGF-β
together
highlighted
extracellular
matrix
remodelling
kidneys
rats.
Interaction
between
TGF-
DN
is
scarce.
Hence,
objective
present
study
to
evaluate
DN.
This
case
control
Study
included
61
cases,
diabetes
Mellitus
controls
healthy
controls.
After
clinical
evaluation
routine
biochemical
parameters
were
estimated
along
TGF-β.
They
analysed
relation
glycemia
correlation
analysis.
Serum
registered
significant
rise
(P
value-<0.001)
comparison
groups.
Their
substantial
association
each
other
glycaemic
status
function
was
correlational
Diagnostic
accuracy
also
sensitivity
specificity.
Multiple
regression
analysis
documented
as
an
independent
determinant
nephropathy.
play
pathogenesis
Prospective
longitudinal
future
Genetic
their
expression
needed
establish
disease
progression.
Journal of Functional Foods,
Journal Year:
2024,
Volume and Issue:
115, P. 106108 - 106108
Published: March 5, 2024
Metabolic
syndrome
(MS),
which
involves
visceral
obesity,
hyperglycemia,
hypertension,
and
dyslipidemia,
has
become
a
global
health
challenge.
Preventive
measures
include
lifestyle
changes,
dietary
treatments,
etc.
Konjac
been
widely
used
as
culinary
ingredient
traditional
Chinese
medicine
in
Asian
countries
for
thousands
of
years.
The
main
component
the
konjac
tuber
is
glucomannan
(KGM),
kind
hydrocolloid
fiber.
Many
problems
diseases
are
affected
by
gut
microbiota,
may
provide
an
alternative
preventing
disease.
In
this
review,
we
describe
prevention
treatment
MS
using
KGM,
with
focus
on
its
impact
relation
to
regulation
microbes.
Developing
comprehensive
understanding
role
played
KGM
via
microbiota
will
help
us
determine
underlying
mechanisms
associated
microbiota.
Clinical Journal of the American Society of Nephrology,
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 29, 2023
Contemporary
guidelines
recommend
the
use
of
sodium-glucose
cotransporter
2
inhibitors
(SGLT2is)
independently
glycemic
control
in
patients
with
type
diabetes
and
those
kidney
disease,
heart
failure,
or
at
high
risk
cardiovascular
disease.
Using
a
large
Israeli
database,
we
assessed
whether
long-term
SGLT2is
versus
dipeptidyl
peptidase
4
(DPP4is)
is
associated
benefits
overall
without
evidence
World Journal of Nephrology,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: Jan. 18, 2025
Kidney
dysfunction
and
reduced
filtration
capacity
due
to
chronic
kidney
disease
(CKD)
lead
a
shift
in
the
body's
acid-base
balance,
ultimately
causing
metabolic
acidosis
(MA).
Sodium
bicarbonate
has
been
used
as
supplement
alleviate
symptoms
reverse
acidosis,
it
may
even
slow
progression
of
CKD.
However,
its
safety
profile
overall
effectiveness
are
uncertain.
To
conduct
systematic
review
meta-analysis
clinical
trials
assessing
sodium
bicarbonate's
efficacy
for
treating
CKD-induced
MA.
Medline,
Scopus,
EMBASE,
Cochrane
Central
were
systematically
searched
from
inception
until
May
2024
select
all
relevant
randomized
control
(RCTs)
non-RCT
(NRCTs)
evaluating
correcting
MA
end-stage
renal
patients.
In
addition,
ClinicalTrials.gov,
Medrxiv.org,
Google
Scholar
other
literature.
A
random-effects
was
performed
derive
mean
differences
(MD)
risk
ratios
(RR)
with
their
95%CI
continuous
dichotomous
outcomes
respectively.
Following
search
databases,
20
RCTs
2
NRCTs
comprising
2932
patients
included
our
study.
The
results
revealed
that
significantly
increased
serum
CKD
(MD:
2.59,
95%CI:
0.95-4.22;
P
=
0.02;
I
95%).
there
non-significant
increase
estimated
glomerular
rate
(eGFR)
on
therapy
0.93,
-1.88-3.75;
0.52;
93%).
Upon
assessment
bicarbonate,
no
significant
association
found
death/prolonged
hospitalization
(RR:
1.05,
0.84-1.32;
0.66;
0%),
or
gastrointestinal
disorders
1.64,
0.35-7.66;
0.53;
76%),
worsening
edema
1.26,
0.94-1.68;
0.12;
37%)
when
compared
control.
halt
function
by
levels
Although
does
not
improve
eGFR,
potentially
prevent
while
maintaining
an
favorable
profile.
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(4), P. 423 - 423
Published: Feb. 10, 2025
Background/Objectives:
Post-translationally
modified
peptide
fragments
of
fetuin-A
(FetA)
were
identified
as
a
potential
biomarker
diabetic
kidney
disease
(DKD).
An
independent
association
between
urinary
FetA-derived
levels
(uPTM3-FetA)
and
DKD
progression
in
patients
with
type
2
diabetes
(T2D)
was
evidenced.
This
study
aimed
to
explore
uPTM3-FetA
excretion
its
associations
insulin
resistance,
inflammatory
metabolic
biomarkers
1
(T1D),
the
normal
albuminuria
estimated
glomerular
filtration
rate
(eGFR)
>
60
mL/min/1.73
m2.
Methods:
aliquots
24
h
urine
specimens,
routine
laboratory
renal,
tests,
adipokines
(leptin,
adiponectin,
resistin),
assessed
glucose
disposal
(eGDR),
measured
cohort
169
adult
T1D
patients.
To
evaluate
changes
early
renal
dysfunction,
divided
according
median
eGFR.
Above-
below-median-eGFR
groups
considered
having
declining
function,
respectively.
Results:
The
(IQR)
level
11.7
(8.43–16.65
µg/24
h),
no
significant
difference
males
females,
well
function
However,
sex-specific
analysis
revealed
significantly
higher
male
lower
eGFRs,
when
compared
those
whereas
such
observed
female
BMI,
hs-CRP,
resistin
HDL-cholesterol
predictors
excretion.
Conclusions:
Our
results
implicate
role
detection
an
dysfunction
T1DM
pinpoint
importance
approach
diagnostics
research.
International Journal of Women s Health,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 449 - 457
Published: Feb. 1, 2025
Women
are
at
increased
risk
of
developing
kidney
disease
and
cardiovascular
(CVD)
in
their
middle
older
ages
due
to
the
impact
aging
hormonal
variation
associated
with
menopause
transition.
diabetes
greater
reduced
function.
Reduced
or
even
mildly
function
enhances
atherosclerotic
(ASCVD)
among
women
type
2
(T2D).
Thus,
objective
this
study
is
determine
association
an
estimated
10-year
ASCVD,
CVD,
factors
T2D
women.
This
cross-sectional
conducted
393
women,
aged
between
40-70
years,
subdivided
into
three
groups
according
level
glomerular
filtration
rate
(eGFR)
(eGFR
≥90
mL/min/1.73m2(normal),
eGFR
60-89
mL/min/1.73m2
(mildly
reduced)
<60
(reduced)).
Association
ASCVD
as
well
was
determined.
Based
on
current
findings,
presence
found
be
(p=0.014)
(p=0.004)
participants
previous
CVD.
No
intermediate/high
for
without
Even
though
significantly
varied
pre
post-menopause
no
observed.
Among
factors,
hypertension
reduced/reduced
study's
findings
highlight
graded,
independent
middle-aged
elderly
while
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 20, 2025
Background
Diabetic
kidney
disease
(DKD),
a
leading
cause
of
chronic
(CKD)
and
end-stage
renal
globally,
is
driven
by
metabolic
inflammatory
processes.
Systemic
immune-inflammation
index
(SII)
platelet-to-lymphocyte
ratio
(PLR)
are
emerging
biomarkers
that
integrate
hematological
components,
potentially
reflecting
severity
dysfunction.
Methods
This
retrospective
study
analyzed
160
patients
from
January
2023
to
December
with
type
2
diabetes
mellitus
(T2DM),
equally
divided
into
proteinuria
non-proteinuria
groups.
SII
PLR
levels
were
compared
between
groups,
their
correlations
urine
albumin-to-creatinine
(ACR)
protein
evaluated
using
statistical
measures,
including
Pearson's
correlation
regression
analyses.
Results
significantly
higher
in
the
group
(SII:
1,305,266
vs.
456,957.4
cells
per
microliter;
PLR:
252.09
99.74,
p<0.001
for
both).
exhibited
strong
positive
ACR
r=0.8537,
r=0.8362)
r=0.834,
r=0.841,
p<0.01
Regression
analysis
revealed
complex,
nonlinear
association
these
increasing
severity,
indicating
dynamic
behavior
across
categories.
HbA1c
demonstrated
parabolic
relationship
ACR,
progressively
larger
effects
at
levels,
highlighting
its
role
worsening
Conclusion
robust
markers
inflammation
injury
T2DM,
showing
associations
ACR.
These
indices,
alongside
HbA1c,
may
aid
early
detection
monitoring
DKD
progression,
particularly
resource-constrained
settings.
Atherosclerosis,
Journal Year:
2025,
Volume and Issue:
403, P. 119146 - 119146
Published: Feb. 24, 2025
Chronic
kidney
disease
(CKD)
is
documented
to
cause
alterations
in
lipid
metabolism,
and
this
was
considered
a
potent
driver
of
increased
cardiovascular
risk.
Among
the
diverse
alteration
traits
CKD,
research
endeavours
have
predominantly
concentrated
on
low-density
lipoproteins
(LDL)
view
pro-atherogenic
role
these
lipoprotein
particles
demonstration
protective
effect
reducing
LDL.
However,
few
studies
focused
metabolism
triglyceride-rich
even
fewer
their
causing
damage.
Therefore,
comprehensive
description
impact
hypertriglyceridemia
(HTG)
CKD
pathophysiology
remains
largely
undetermined.
This
reflects
difficulty
disentangling
independent
triglycerides
(TG)
complex,
bidirectional
relationship
between
TG
disease.
Abnormal
neutral
accumulation
intrarenal
vasculature
renal
cells
eventually
due
HTG
may
also
promote
glomerular
injury,
throughout
mechanisms
including
oxidative
stress,
mitochondrial
dysfunction
proinflammatory
responses.
While
epidemiological
experimental
evidence
suggests
potential
damage,
causal
clinical
relevance
remain
unclear,
representing
significant
area
for
future
investigation.
review
aims
highlight
intricate
interplay
disease,
shedding
light
through
which
influence
functionality.